Intercept Pharmaceuticals, Inc (ICPT) Covered Calls

Intercept Pharmaceuticals, Inc covered calls Intercept Pharmaceuticals Inc is a development stage, biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver disease utilizing its proprietary bile acid chemistry.

You can sell covered calls on Intercept Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ICPT (prices last updated Wed 4:16 PM ET):

Intercept Pharmaceuticals, Inc (ICPT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
110.70 +6.11 107.25 115.00 439K - 0.0B
Covered Calls For Intercept Pharmaceuticals, Inc (ICPT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 111 2.85 112.15 -1.0% -36.5%
Jan 18 110 9.00 106.00 3.8% 36.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Intercept Pharmaceuticals, Inc. is a development stage biopharmaceutical company. It focuses on the discovering, developing and commercializing of novel therapeutics to treat chronic liver diseases utilizing its proprietary bile acid chemistry. It develops obeticholic acid, a bile acid analog that is in Phase III clinical trials for the treatment of primary biliary cirrhosis; in Phase IIa clinical trial to treat portal hypertension; in Phase II clinical trial for the treatment of alcoholic hepatitis; in Phase IIb clinical trial for the treatment of nonalcoholic steatohepatitis; and in Phase IIa clinical trial to treat bile acid diarrhea. Intercept Pharmaceuticals was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.